Search

everythinglearnresearchcommunity

for

Search:↓

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

The woman's hair loss pattern doesn't match typical conditions like alopecia areata or female pattern hair loss.

Platelet-rich plasma (PRP) is a simple, cost-effective treatment that promotes hair growth and reduces hair loss, with high patient satisfaction.

Most women undergoing chemotherapy experience hair loss, and many cope by using wigs or bonnets.

Many pediatric epilepsy patients experience preventable severe adverse drug reactions, especially with certain medications and risk factors.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

The document concludes that transsexual individuals often experience improved quality of life after transitioning, despite higher risks of psychiatric issues and mortality.

Women with PCOS are much more likely to experience depression.

Stress-related hair loss was reversed with a special medication.

Women with type D personality and PCOS experience more stress and use less effective coping strategies.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Some people who got COVID-19 experienced temporary hair loss starting around 10 weeks after infection, with many seeing improvement within about 25 days.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Platelet-rich plasma treatment could potentially be an effective way to treat chronic alopecia areata with minimal side effects.

Low-level laser therapy helps increase hair growth in female pattern hair loss but not in telogen effluvium.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

Topiramate may cause reversible hair loss.

Most end-stage renal disease patients in Jordan have skin issues like dryness and itching.

An 18-year-old with hair loss saw hair regrowth after treatments combining microneedling, cupping, medication, and oil application.

People with facial disfigurements are judged more negatively, highlighting the social benefits of corrective surgery.

Testosterone treatment in transgender teens can worsen acne, requiring careful treatment due to mental health and medication side effects.

People with a family history of hair loss are more likely to experience it, and the severity of hair loss is linked to insulin resistance. The connection between early hair loss and oxidative stress needs more investigation.

Discontinuing topical minoxidil can resolve headaches and dizziness.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Some alternative treatments may help with hair loss, but more evidence is needed to confirm their effectiveness.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

COVID-19 infection can significantly cause temporary hair loss.

Men with a family history of hair loss are more likely to experience it themselves, especially if both parents have hair loss.

Behavioral therapies are more effective than drugs for treating trichotillomania.